Grant: Master's Award: Canada Graduate Scholarships
McGill University
$17,500.00
Immunogenic characterization of plant-specific glyco-epitopes present on influenza virus-like particle vaccines produced in Nicotiana benthamiana
FY 2014-15
Summary
Recent innovations in plant biotherapeutics have yielded a novel virus-like particle (VLP) vaccine against influenza virus that elicits enhanced immunoprotection compared to current egg-based vaccines. Enveloped VLPs produced in Nicotiana benthamiana are studded with the hemagglutinin (HA) protein of the target influenza strain(s), which is uniquely glycosylated using plant-specific glyco-epitopes. Previous investigations have demonstrated that these epitopes are safe for use in humans, however little is known about how plant-specific glycans contribute to the immune response elicited by plant-made influenza VLPs. During influenza infection, pattern recognition receptors on antigen presenting cells (APCs) interact with HA-associated glycans to initiate virus internalization, therefore glycans present on HA likely promote VLP uptake. Furthermore, plant glycans are naturally immunogenic in humans, therefore these unique epitopes may contribute to vaccine immunogenicity by enhancing VLP uptake and activation of APCs. The contribution of plant glycosylation to vaccine immunogenicity will be investigated by electron microscopy and flow cytometry before and after glycan modification or deglycosylation of HA present on VLPs. In parallel, a ferret challenge model will be optimized to assess the impact of these modifications on vaccine efficacy. This study will be the first investigation of a plausible correlate of immunogenicity in plant-made VLP vaccines, and information obtained will be used to optimize the existing model for consistent production of highly effective vaccines.
Department
Program
Master's Award: Canada Graduate Scholarships
Recipient
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
331539
Name
Hendin Hilary
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Immunogenic characterization of plant-specific glyco-epitopes present on influenza virus-like particle vaccines produced in Nicotiana benthamiana
Programtype2
Studentship Programs
Orgnameinp2
McGill University
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Cell-Mediated Immunity; Glycoimmunology; Influenza Virus; Nicotiana Benthamiana; Plant-Specific Glycans; Vaccine; Virus-Like Particle
Abstract
Recent innovations in plant biotherapeutics have yielded a novel virus-like particle (VLP) vaccine against influenza virus that elicits enhanced immunoprotection compared to current egg-based vaccines. Enveloped VLPs produced in Nicotiana benthamiana are studded with the hemagglutinin (HA) protein of the target influenza strain(s), which is uniquely glycosylated using plant-specific glyco-epitopes. Previous investigations have demonstrated that these epitopes are safe for use in humans, however little is known about how plant-specific glycans contribute to the immune response elicited by plant-made influenza VLPs. During influenza infection, pattern recognition receptors on antigen presenting cells (APCs) interact with HA-associated glycans to initiate virus internalization, therefore glycans present on HA likely promote VLP uptake. Furthermore, plant glycans are naturally immunogenic in humans, therefore these unique epitopes may contribute to vaccine immunogenicity by enhancing VLP uptake and activation of APCs. The contribution of plant glycosylation to vaccine immunogenicity will be investigated by electron microscopy and flow cytometry before and after glycan modification or deglycosylation of HA present on VLPs. In parallel, a ferret challenge model will be optimized to assess the impact of these modifications on vaccine efficacy. This study will be the first investigation of a plausible correlate of immunogenicity in plant-made VLP vaccines, and information obtained will be used to optimize the existing model for consistent production of highly effective vaccines.
Competitiondate
201412
Approvedterm2
1 yr 0 mth
Pinamesdelim
Hendin, Hilary
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~